Segment Reporting - Reconciliation of Adjusted EBITDA (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Segment Reporting [Abstract] | ||||
| Net Income (Loss) Attributable to Evolent Health, Inc. | $ (12,429) | $ (12,588) | $ (35,971) | $ (47,506) |
| Interest income | 968 | 411 | 2,918 | 813 |
| Interest expense | (853) | (880) | (2,561) | (2,781) |
| (Provision) benefit for income taxes | (135) | 1,714 | (29) | 2,009 |
| Depreciation and amortization expenses | (10,352) | (7,717) | (29,882) | (21,236) |
| Income (loss) from equity method investees | (1,381) | (369) | (2,787) | (1,446) |
| Change in fair value of contingent consideration and indemnification asset | (100) | (100) | 1,404 | (300) |
| Other income (expense), net | (124) | 15 | (64) | 21 |
| Net income (loss) attributable to non-controlling interests | 126 | 541 | 680 | 8,471 |
| ASC 606 transition adjustments | 0 | 0 | (4,498) | 0 |
| Purchase accounting adjustments | (214) | (449) | (647) | (1,224) |
| Stock-based compensation expense | (4,047) | (5,708) | (12,560) | (16,172) |
| Severance costs | 0 | 0 | (1,489) | 0 |
| Amortization of contract cost assets | (658) | 0 | (1,797) | 0 |
| Transaction costs | (456) | (2,694) | (2,254) | (9,972) |
| Adjusted EBITDA | $ 4,797 | $ 2,648 | $ 17,595 | $ (5,689) |
| X | ||||||||||
- Definition Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization No definition available.
|
| X | ||||||||||
- Definition Adjustments For Initial Application Period Cumulative Effect Transition No definition available.
|
| X | ||||||||||
- Definition Capitalized Contract Cost, Amortization, Purchase Accounting Adjustments No definition available.
|
| X | ||||||||||
- Definition Purchase Accounting Adjustments No definition available.
|
| X | ||||||||||
- Definition Transaction Costs No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|